Jubilant Pharmova Ltd. (JUBLPHARMA): Jubilant Pharmova Share Price rises 5.37% as stock gains on trade

Jubilant Pharmova Share Price is trading at Rs 1,004, up 5.37% from the previous close, with market capitalisation at Rs 14,713.6 crore. The move makes Jubilant Pharmova a notable stock gaining today in the Indian stock market, although the latest Univest data does not establish a company-specific catalyst. For readers tracking Jubilant Pharmova Share Price Today, the key question is whether the price rise is being supported by valuation, sector context and the company’s financial profile rather than any fresh corporate trigger.

The stock opened at Rs 964.8, touched a high of Rs 1,009 and a low of Rs 953.75, and was last traded at Rs 1,004. That places Jubilant Pharmova Share Price above the previous close of Rs 952.8 by Rs 51.2. In Stock Market Today terms, this is a clear intraday share price gain, and it places the name among Stocks Rising Today and Top Gainers Today for attention-seeking investors. Univest will continue to track Jubilant Pharmova Share Price Live as market participants assess whether the move holds alongside the company’s broader stock performance.

Jubilant Pharmova Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,004
Previous Close	Rs 952.8
Today's Move	Rs 51.2 (+5.37%)
Open	Rs 964.8
High	Rs 1,009
Low	Rs 953.75
Turnover	Rs 3.67 crore
Market Capitalisation	Rs 14,713.6 crore
Market Cap Category	Mid Cap

Jubilant Pharmova Ltd. (JUBLPHARMA) rose to Rs 1,004 from the previous close of Rs 952.8, a move of Rs 51.2 or 5.37%. The stock opened at Rs 964.8, reached a high of Rs 1,009, recorded a low of Rs 953.75.

Jubilant Pharmova Share Price moved sharply higher in today’s trade, with the stock opening above the previous close, extending higher during the day and last trading near the top of the range. The move reflects a solid price rise in a single session, but the latest Univest data confirms the event without establishing a fresh stock-specific trigger. For readers searching Jubilant Pharmova Stock News or Jubilant Pharmova Share News, the important point is the size of the intraday gain and the fact that the stock remained bid through the move. That is why Univest identifies it as one of the active market movers in Healthcare today.

Jubilant Pharmova Ltd. (JUBLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 14,713.6 crore
P/E Ratio	43.1x
P/B Ratio	2.13x
ROE	5.97%
ROCE	8.69%
EPS	Rs 22.11
Book Value Per Share	Rs 447.64
Dividend Yield	0.52%

Jubilant Pharmova Ltd. (JUBLPHARMA) fundamental metrics show P/E 43.1x, P/B 2.13x, ROE 5.97%, ROCE 8.69%. These figures provide context only and are not a buy or sell signal.

Jubilant Pharmova Ltd. has a market capitalisation of Rs 14713.6 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.1x, P/B at 2.13x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 5.97% and ROCE of 8.69%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 22.11, book value per share of Rs 447.64, dividend yield of 0.52%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	43.1x
Benchmark Median P/E	32.52x
Benchmark Average P/E	49x
Benchmark P/E Range	3.35x to 654.07x
Company P/B Ratio	2.13x
Benchmark Median P/B	3x
Company ROE	5.97%
Benchmark Median ROE	11.82%
Company ROCE	8.69%
Benchmark Median ROCE	13.71%
Company Market Capitalisation	Rs 14,713.6 crore
Benchmark Median Market Cap	Rs 701.65 crore

Jubilant Pharmova Ltd. (JUBLPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Jubilant Pharmova Ltd. (JUBLPHARMA) has a P/E ratio of 43.1x, which is above the benchmark median of 32.52x, a difference of +32.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Jubilant Pharmova Ltd. (JUBLPHARMA) has a ROE of 5.97%, which is below the benchmark median of 11.82%, a difference of -49.49%. Jubilant Pharmova Ltd. (JUBLPHARMA) has a ROCE of 8.69%, which is below the benchmark median of 13.71%, a difference of -36.62%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,55,633.71	37.69	5.27	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,41,576.41	84.45	13.99	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,84,478.41	85.68	20.82	26.76	19.27
Cipla Ltd.	CIPLA	1,11,888.39	33.46	3.21	11.83	16
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,11,820.18	25.53	4.27	19.69	21.39

Jubilant Pharmova Ltd. (JUBLPHARMA) has a P/E ratio of 43.1x compared with the displayed peer median of 37.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 5.97% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 8.69% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Jubilant Pharmova Ltd. (JUBLPHARMA) has a market capitalisation of Rs 14,713.6 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Jubilant Pharmova

• Jubilant Pharmova Share Price rose 5.37% today to Rs 1,004, making it a notable stock gaining today.
• The intraday move kept the stock near the day’s higher levels, which has drawn attention in Stock Market Today updates.
• Its P/B of 2.13 is below the industry median, adding valuation interest for fundamental analysis readers.
• ROE of 5.97 and ROCE of 8.69 sit below the same-industry benchmark, so investors are comparing growth against return quality.
• Jubilant Pharmova Share Price is also being watched against larger pharma peers with much higher market capitalisation.

About Jubilant Pharmova

Jubilant Pharmova Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known in the market for its pharma-focused business profile, and investors typically track Jubilant Pharmova Stock News for updates linked to business performance, earnings visibility and sector positioning. In today’s context, the company’s market capitalisation of Rs 14,713.6 crore places it well below the largest listed pharma names, but still within a meaningful mid-cap bracket.

From a company overview angle, Jubilant Pharmova Share Price is relevant because the stock combines a listed healthcare business with valuation metrics that are watched closely by market participants. The company’s P/E of 43.1, P/B of 2.13, EPS of 22.11, book value of Rs 447.64 and dividend yield of 0.52% help frame investor attention around quality and pricing. Univest uses these figures to keep the discussion anchored in company financials rather than speculation.

Frequently Asked Questions

Why is Jubilant Pharmova Share Price rising today?

Ans. Jubilant Pharmova Share Price rose 5.37% to Rs 1,004 today. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst for the gain.

What is Jubilant Pharmova Share Price today?

Ans. Jubilant Pharmova Share Price today is Rs 1,004. It is trading above the previous close of Rs 952.8 after adding Rs 51.2 in the current market move. The stock moved 5.37% so far today.

What is Jubilant Pharmova market capitalisation?

Ans. Jubilant Pharmova’s market capitalisation is Rs 14,713.6 crore. That places the company above the industry median in its sector benchmark, though below the largest listed pharma peers. The company operates in the Healthcare sector.

Is Jubilant Pharmova expensive on valuation?

Ans. Jubilant Pharmova trades at a P/E of 43.1 and a P/B of 2.13. The P/E is above the industry median but below the industry average, while P/B stays below both.

How do Jubilant Pharmova profits and returns look?

Ans. Jubilant Pharmova reports EPS of 22.11, ROE of 5.97 and ROCE of 8.69. Those return ratios are below the industry medians, so the quality profile looks moderate.

What does Jubilant Pharmova book value show?

Ans. Jubilant Pharmova book value is Rs 447.64 per share. Book value is an accounting measure of net worth per share and helps investors compare price with balance-sheet support.

Does Jubilant Pharmova pay a dividend?

Ans. Jubilant Pharmova has a dividend yield of 0.52%. Dividend yield reflects historical or current payout relative to price, so investors usually read it alongside earnings and valuation.

How does Jubilant Pharmova compare with pharma peers?

Ans. Jubilant Pharmova is much smaller than Sun Pharma, Divi’s Laboratories, Torrent Pharma, Cipla and Zydus Lifesciences by market cap. Its lower P/B also contrasts with the peer group.

Track Jubilant Pharmova Share Price on Univest

Use Jubilant Pharmova Ltd. (JUBLPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Jubilant Pharmova Share Price on Univest for live price movement, market capitalisation, fundamental ratios, 52-week levels and broader market insights. The platform also helps readers follow Jubilant Pharmova Share Price Today alongside company news, sector context and peer comparison in one place. For anyone scanning Jubilant Pharmova Latest News, Univest keeps the focus on factual stock analysis and financial analysis.